{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:10:00Z","timestamp":1792725000846,"version":"4.5.0"},"reference-count":50,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"unspecified","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Fam Med Com Health"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate whether COVID-19 infection was associated with increased risk for incident respiratory syncytial virus (RSV) infections and associated diseases among young children that might have contributed to the 2022 surge of severe paediatric RSV cases in the USA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>This is a retrospective population-based cohort study. Five outcomes were examined, including overall RSV infection, positive lab test-confirmed RSV infection, clinically diagnosed RSV diseases, RSV-associated bronchiolitis and unspecified bronchiolitis. Risk ratio (RR) and 95% CI of the outcomes that occurred during the 2022 and 2021 RSV seasons were calculated by comparing propensity-score matched cohorts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Nationwide multicentre database of electronic health records (EHRs) of 61.4\u2009million patients in the USA including 1.7\u2009million children 0\u20135 years of age, which was accessed through TriNetX Analytics that provides web-based and secure access to patient EHR data from hospitals, primary care and specialty treatment providers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>The study population consisted of 228\u2009940 children of 0\u20135 years with no prior RSV infection who had medical encounters in October 2022. Findings were replicated in a separate study population of 370\u2009919 children of 0\u20135 years with no prior RSV infection who had medical encounters in July 2021\u2013August 2021 during a non-overlapping time period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>For the 2022 study population (average age 2.4 years, 46.8% girls, 61% white, 16% black), the risk for incident RSV infection during October 2022<jats:bold>\u2013<\/jats:bold>December 2022 was 6.40% for children with prior COVID-19 infection, higher than 4.30% for the matched children without COVID-19 (RR 1.40, 95%\u2009CI 1.27 to 1.55); and among children aged 0<jats:bold>\u2013<\/jats:bold>1\u2009year, the overall risk was 7.90% for those with prior COVID-19 infection, higher than 5.64% for matched children without (RR 1.40, 95%\u2009CI 1.21 to 1.62). For the 2021 study population (average age 2.2 years, 46% girls, 57% white, 20% black), the risk for incident RSV infection during July 2021<jats:bold>\u2013<\/jats:bold>December 2021 was 4.85% for children with prior COVID-19 infection, higher than 3.68% for the matched children without COVID-19 (RR 1.32, 95%\u2009CI 1.12 to 1.56); and 7.30% for children aged 0<jats:bold>\u2013<\/jats:bold>1\u2009year with prior COVID-19 infection, higher than 4.98% for matched children without (RR 1.47, 95%\u2009CI 1.18 to 1.82).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>COVID-19 was associated with a significantly increased risk for RSV infections among children aged 0\u20135 years in 2022. Similar findings were replicated for a study population of children aged 0\u20135 years in 2021. Our findings suggest that COVID-19 contributed to the 2022 surge of RSV cases in young children through the large buildup of COVID-19-infected children and the potential long-term adverse effects of COVID-19 on the immune and respiratory system.<\/jats:p><\/jats:sec>","DOI":"10.1136\/fmch-2023-002456","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T14:36:31Z","timestamp":1697207791000},"page":"e002456","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":31,"title":["Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0\u20135 years in the USA in 2022: a multicentre retrospective cohort study"],"prefix":"10.1136","volume":"11","author":[{"given":"Lindsey","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela B","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Kaelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Volkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3127-4795","authenticated-orcid":false,"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"2023101307351474000_11.4.e002456.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804877"},{"key":"2023101307351474000_11.4.e002456.2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7029a1"},{"key":"2023101307351474000_11.4.e002456.3","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1001\/jama.2022.21638","article-title":"This is our COVID\u201d\u2014what physicians need to know about the pediatric RSV surge","volume":"328","author":"Abbasi","year":"2022","journal-title":"JAMA"},{"key":"2023101307351474000_11.4.e002456.4","doi-asserted-by":"crossref","unstructured":"Willyard C . Flu and colds are back with a vengeance \u2014 why now? Nature 2022. doi:10.1038\/d41586-022-03666-9 [Epub ahead of print 10 Nov 2022].","DOI":"10.1038\/d41586-022-03666-9"},{"key":"2023101307351474000_11.4.e002456.5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMc2216153","article-title":"Viral lineages in the 2022 RSV surge in the United States","volume":"388","author":"Adams","year":"2023","journal-title":"N Engl J Med"},{"key":"2023101307351474000_11.4.e002456.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01277-6"},{"key":"2023101307351474000_11.4.e002456.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2021.05.004"},{"key":"2023101307351474000_11.4.e002456.8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1473-3099(22)00544-8","article-title":"Quantifying the RSV immunity debt following COVID-19: a public health matter","volume":"23","author":"Billard","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2023101307351474000_11.4.e002456.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2013182117"},{"key":"2023101307351474000_11.4.e002456.10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(22)00525-4","article-title":"Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study","volume":"23","author":"Bardsley","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2023101307351474000_11.4.e002456.11","doi-asserted-by":"crossref","unstructured":"Lenglart L , Ouldali N , Honeyford K , et al . Respective roles of non-pharmaceutical interventions in bronchiolitis outbreaks: an interrupted time-series analysis based on a multinational surveillance system. Eur Respir J 2023;61:2201172. doi:10.1183\/13993003.01172-2022","DOI":"10.1183\/13993003.01172-2022"},{"key":"2023101307351474000_11.4.e002456.12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MOP.0000000000001221","article-title":"Diagnosis and management of post-COVID (long COVID) in children: a moving target","volume":"35","author":"Morello","year":"2023","journal-title":"Curr Opin Pediatr"},{"key":"2023101307351474000_11.4.e002456.13","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003328"},{"key":"2023101307351474000_11.4.e002456.14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"2023101307351474000_11.4.e002456.15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1473-3099(23)00053-1","article-title":"Why we need a deeper understanding of the pathophysiology of long COVID","volume":"23","author":"Iwasaki","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2023101307351474000_11.4.e002456.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01113x"},{"key":"2023101307351474000_11.4.e002456.17","doi-asserted-by":"crossref","unstructured":"Haunhorst S , Bloch W , Javelle F , et al . A Scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of long COVID? Front Immunol 2022;13:1070994. doi:10.3389\/fimmu.2022.1070994","DOI":"10.3389\/fimmu.2022.1070994"},{"key":"2023101307351474000_11.4.e002456.18","unstructured":"TriNetX . Trinetx. Available: https:\/\/trinetx.com\/ [Accessed 24 Dec 2022]."},{"key":"2023101307351474000_11.4.e002456.19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamapediatrics.2022.0945","article-title":"Incidence rates and clinical outcomes of SARS-Cov-2 infection with the Omicron and Delta variants in children younger than 5 years in the US","volume":"176","author":"Wang","year":"2022","journal-title":"JAMA Pediatr"},{"key":"2023101307351474000_11.4.e002456.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0210"},{"key":"2023101307351474000_11.4.e002456.21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/alz.12669","article-title":"COVID-19 breakthrough infections and hospitalizations among vaccinated patients with dementia in the United States between December 2020 and August 2021","volume":"19","author":"Wang","year":"2023","journal-title":"Alzheimers Dement"},{"key":"2023101307351474000_11.4.e002456.22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jamaoncol.2022.1096","article-title":"Breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in vaccinated patients with cancer in the US between December 2020 and November 2021","volume":"8","author":"Wang","year":"2022","journal-title":"JAMA Oncol"},{"key":"2023101307351474000_11.4.e002456.23","doi-asserted-by":"crossref","first-page":"100931","DOI":"10.1016\/j.blre.2022.100931","article-title":"COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: a clarion call for maintaining mitigation and ramping-up research","volume":"54","author":"Wang","year":"2022","journal-title":"Blood Rev"},{"key":"2023101307351474000_11.4.e002456.24","doi-asserted-by":"crossref","unstructured":"Wang L , Berger NA , Xu R . Risks of SARS-CoV-2 breakthrough infection and hospitalization in fully vaccinated patients with multiple myeloma. JAMA Netw Open 2021;4:e2137575. doi:10.1001\/jamanetworkopen.2021.37575","DOI":"10.1001\/jamanetworkopen.2021.37575"},{"key":"2023101307351474000_11.4.e002456.25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-220717","article-title":"Association of COVID-19 with new-onset Alzheimer\u2019s disease","volume":"89","author":"Wang","year":"2022","journal-title":"JAD"},{"key":"2023101307351474000_11.4.e002456.26","doi-asserted-by":"crossref","unstructured":"Pan Y , Davis PB , Kaebler DC , et al . Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. Cardiovasc Diabetol 2022;21:170. doi:10.1186\/s12933-022-01610-9","DOI":"10.1186\/s12933-022-01610-9"},{"key":"2023101307351474000_11.4.e002456.27","doi-asserted-by":"crossref","unstructured":"Kendall EK , Olaker VR , Kaelber DC , et al . Association of SARS-CoV-2 infection with new-onset type 1 diabetes among pediatric patients from 2020 to 2021. JAMA Netw Open 2022;5:e2233014. doi:10.1001\/jamanetworkopen.2022.33014","DOI":"10.1001\/jamanetworkopen.2022.33014"},{"key":"2023101307351474000_11.4.e002456.28","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.3390\/cancers14194948","article-title":"Time trend and association of early-onset colorectal cancer with diverticular disease in the United States: 2010-2021","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"key":"2023101307351474000_11.4.e002456.29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/wps.20921","article-title":"Increased risk for COVID\u201019 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021","volume":"21","author":"Wang","year":"2022","journal-title":"World Psychiatry"},{"key":"2023101307351474000_11.4.e002456.30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41380-022-01903-1","article-title":"Association of COVID-19 with Endocarditis in patients with cocaine or opioid use disorders in the US","volume":"28","author":"Wang","year":"2023","journal-title":"Mol Psychiatry"},{"key":"2023101307351474000_11.4.e002456.31","doi-asserted-by":"crossref","unstructured":"Olaker VR , Kendall EK , Wang CX , et al . Association of recent SARS-CoV-2 infection with new-onset alcohol use disorder. JAMA Netw Open 2023;6:e2255496. doi:10.1001\/jamanetworkopen.2022.55496","DOI":"10.1001\/jamanetworkopen.2022.55496"},{"key":"2023101307351474000_11.4.e002456.32","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/add.16168","article-title":"Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence-based prediction, expert evaluation, clinical corroboration and mechanism of action analyses","volume":"118","author":"Gao","year":"2023","journal-title":"Addiction"},{"key":"2023101307351474000_11.4.e002456.33","doi-asserted-by":"crossref","unstructured":"Gao Z , Gorenflo M , Kaelber DC , et al . Drug repurposing for reducing the risk of cataract extraction in patients with diabetes mellitus: integration of artificial intelligence-based drug prediction and clinical corroboration. Front Pharmacol 2023;14:1181711. doi:10.3389\/fphar.2023.1181711","DOI":"10.3389\/fphar.2023.1181711"},{"key":"2023101307351474000_11.4.e002456.34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3233\/JAD-220901","article-title":"Association of aspirin use with reduced risk of developing Alzheimer\u2019s disease in elderly ischemic stroke patients: a retrospective cohort study","volume":"91","author":"Gorenflo","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"2023101307351474000_11.4.e002456.35","doi-asserted-by":"crossref","unstructured":"Wang L , Volkow ND , Berger NA , et al . Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder. J Clin Psychol 2023. doi:10.1002\/jclp.23582 [Epub ahead of print 16 Aug 2023].","DOI":"10.1002\/jclp.23582"},{"key":"2023101307351474000_11.4.e002456.36","doi-asserted-by":"publisher","DOI":"10.2174\/1874285801105010144"},{"key":"2023101307351474000_11.4.e002456.37","unstructured":"CDC . Underlying medical conditions associated with higher risk for severe COVID-19: information for healthcare professionals. Centers for Disease Control and Prevention, 2023. Available: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/underlyingconditions.html"},{"key":"2023101307351474000_11.4.e002456.38","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7214a1"},{"key":"2023101307351474000_11.4.e002456.39","unstructured":"CDC, Centers for Disease Control and Prevention . Wearing masks in travel and public transportation settings. Centers for Disease Control and Prevention, 2022. Available: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/travelers\/masks-public-transportation.html"},{"key":"2023101307351474000_11.4.e002456.40","unstructured":"Children and COVID-19: state-level data report. 2022. Available: https:\/\/www.aap.org\/en\/pages\/2019-novel-coronavirus-covid-19-infections\/children-and-covid-19-state-level-data-report\/ [Accessed 31 Oct 2022]."},{"key":"2023101307351474000_11.4.e002456.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01367-z"},{"key":"2023101307351474000_11.4.e002456.42","doi-asserted-by":"crossref","first-page":"e745","DOI":"10.1016\/S2666-5247(23)00115-5","article-title":"Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies","volume":"4","author":"Buonsenso","year":"2023","journal-title":"Lancet Microbe"},{"key":"2023101307351474000_11.4.e002456.43","doi-asserted-by":"crossref","unstructured":"Buonsenso D , Valentini P , De Rose C , et al . Recovering or persisting: the immunopathological features of SARS-CoV-2 infection in children. J Clin Med 2022;11:4363. doi:10.3390\/jcm11154363","DOI":"10.3390\/jcm11154363"},{"key":"2023101307351474000_11.4.e002456.44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4149\/av_2020_203","article-title":"T cells and their function in the immune response to viruses","volume":"64","author":"Be\u0148ov\u00e1","year":"2020","journal-title":"Acta Virol"},{"key":"2023101307351474000_11.4.e002456.45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800096"},{"key":"2023101307351474000_11.4.e002456.46","doi-asserted-by":"crossref","unstructured":"Camporesi A , Morello R , Ferro V , et al . Epidemiology, microbiology and severity of bronchiolitis in the first post-lockdown cold season in three different geographical areas in Italy: a prospective, observational study. Children (Basel) 2022;9:491. doi:10.3390\/children9040491","DOI":"10.3390\/children9040491"},{"key":"2023101307351474000_11.4.e002456.47","doi-asserted-by":"crossref","unstructured":"Camporesi A , Morello R , Pierucci UM , et al . And 2022\/23 post-pandemic bronchiolitis seasons in two major Italian cities: a prospective study. Children (Basel) 2023;10:1081. doi:10.3390\/children10061081","DOI":"10.3390\/children10061081"},{"key":"2023101307351474000_11.4.e002456.48","doi-asserted-by":"publisher","DOI":"10.3201\/eid2802.211727"},{"key":"2023101307351474000_11.4.e002456.49","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jamapediatrics.2021.2770","article-title":"Association of age and pediatric household transmission of SARS-CoV-2 infection","volume":"175","author":"Paul","year":"2021","journal-title":"JAMA Pediatr"},{"key":"2023101307351474000_11.4.e002456.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2020.05.006"}],"container-title":["Family Medicine and Community Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/fmch-2023-002456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T14:36:46Z","timestamp":1697207806000},"score":1,"resource":{"primary":{"URL":"https:\/\/fmch.bmj.com\/lookup\/doi\/10.1136\/fmch-2023-002456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,10,13]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/fmch-2023-002456"],"URL":"https:\/\/doi.org\/10.1136\/fmch-2023-002456","relation":{},"ISSN":["2305-6983","2009-8774"],"issn-type":[{"value":"2305-6983","type":"print"},{"value":"2009-8774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}